BiomX Inc.

As of June 30, 2026, BiomX Inc. carries a market capitalization of 4.38M, placing it among publicly traded companies globally. Its enterprise value stands at 20.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BiomX Inc.'s next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, BiomX Inc. has 1.26M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 4.23, and the price-to-book ratio stands at 1.01.

These figures are as of June 30, 2026. The EV/Sales ratio of 61.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 20.45M versus a market cap of 4.38M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, BiomX Inc. maintains a current ratio of 0.24, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.15, indicating elevated leverage, while an interest coverage ratio of 58.94 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, BiomX Inc. posted a negative return on equity (ROE) of -1,869.73, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -137.13, reflecting losses generated across the asset base. The company generates approximately 11,350.43 in revenue per employee across its workforce of 29.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, BiomX Inc. recorded 4,000.00 in income tax expense. The company reported a pretax loss of -45.48M and -45.41M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 2, 2026, BiomX Inc.'s stock has declined approximately 99.64% over the past 52 weeks. The 50-day moving average sits at 1.28, while the 200-day moving average is 19.53.

Over the twelve months ended June 30, 2026, BiomX Inc. generated 332,000.00 in revenue and converted that into -45.41M in net income, yielding earnings per share of -112.57. EBITDA reached -30.59M, while operating income came in at -22.44M.

As of June 30, 2026, BiomX Inc. holds 572,000.00 in cash and equivalents against 3.37M in total debt, resulting in a net debt position of 3.01M. Total book value stands at 4.35M, with working capital of -7.76M providing operational flexibility.

BiomX Inc. produced -18.15M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2,000.00 in capital expenditures, free cash flow totaled -18.15M - equivalent to -44.93 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -6,759.34 and net profit margin of -13,679.22 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 0.19 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -1,291.81: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -110.37, meaning BiomX Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

BiomX Inc.'s most recent stock split took place on September 9, 2026 with a 10:1 split ratio.

As of June 30, 2026, BiomX Inc. has an Altman Z-Score of -163.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.